Skip to main content

Table 1 Patient characteristics

From: The prognostic value of the nodal ratio in N1 breast cancer

 

No. of patients (%)

   
 

NR < 0.15

(n = 100)

NR > 0.15

(n = 30)

p value

Total

(n = 130)

Age (years)

  

0.225

 

   median (range)

46 (25-79)

50 (32-82)

 

47 (25-82)

Excised LN (No.)

  

< 0.001

 

   median (range)

20 (7-59)

7 (1-18)

 

18 (1-59)

Breast resection

  

0.290

 

   BCS

49 (49.0)

18 (60.0)

 

67 (51.5)

   MRM

51 (51.0)

12 (40.0)

 

63 (48.5)

LN resection

  

0.071

 

   SLNB only

3 (3.0)

4 (13.3)

 

7 (5.4)

   SLNB + ALND

68 (68.0)

20 (66.7)

 

88 (67.7)

   ALND

29 (29.0)

6 (20.0)

 

35 (26.9)

Radiotherapy

  

0.047

 

   no

54 (54.0)

10 (33.3)

 

64 (49.2)

   yes

46 (46.0)

20 (66.7)

 

66 (50.8)

Extent of radiotherapy

  

0.001

 

   local

41 (89.1)

10 (50.0)

 

51 (77.2)

   locoregional

5 (10.9)

10 (50.0)

 

15 (22.8)

Chemotherapy

  

0.176

 

   no

8 (8.0)

5 (16.7)

 

13 (10.0)

   yes

92 (92.0)

25 (83.3)

 

117 (90.0)

Regimen

  

0.141

 

   CMF

12 (13.0)

7 (28.0)

 

19 (16.2)

   FEC/FAC

31 (33.7)

9 (36.0)

 

40 (34.2)

   ACT

49 (53.3)

9 (36.0)

 

58 (49.6)

  1. Abbreviations: LN, lymph node; BCS, breast-conserving surgery; MRM, modified radical mastectomy; SLNBx, sentinel lymph node biopsy; ALND, axillary lymph node dissection; CMF, cyclophosphamide/methotrexate/5-fluorouracil; FEC, 5-FU/epirubicin/cyclophosphamide; FAC, 5-FU/adriamycin/cyclophosphamide; ACT, adriamycin/cyclophosphamide/paclitaxel